Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in

Prof. Fabrice Barlesi

Fabrice Barlesi

Professor of Medicine, Paris-Saclay University, Paris, France, & General Director of the Gustave Roussy, Paris, France

Prof. Fabrice Barlesi is a Professor of Medicine at the Paris-Saclay University, Paris, France & General Director of the Gustave Roussy, Paris, France.

He is co-founder of Marseille Immunopôle, which aims to coordinate immunological expertise in the Aix-Marseille metropolitan area. He leads the Pioneer Project, a major international research program with the objective of improving understanding of resistance to anti-PD-1/PD-L1 immunotherapy in lung cancer and preventing and overcoming it.

His research focuses on lung cancer, precision medicine and cancer immunology.

print
PRINT

Featured content

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Webinar | 08-11-2023 | 18:00 (CET)

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Image Credits